PUBLICATIONS

2024

  • Ren, Guo, Lin, Chen, Long, Xu's paper entitled "Targeting cytohesin-1 suppresses acute myeloid leukemia progression and overcomes resistance to ABT-199." has been accepted by Acta Pharmacol Sin. Link
  • 2023

  • Cheng, Xiang, Gale, Chen, Qu, Guo's paper entitled "SARS-CoV-2 Omicron BA.5.2-infection and COVID-19 in persons with chronic myeloid leukaemia." has been accepted by J Cancer Res Clin.
  • 2022

  • Cao, Chen, Lei, Gao, Ren's paper entitled "The transplantation of rapamycin-treated senescent human mesenchymal stem cells with enhanced proangiogenic activity promotes neovascularization and ischemic limb salvage in mice." has been accepted by Acta Pharmacol Sin.
  • Cao, Chen, Lei, Gao, Ren's paper entitled "COVID-19 in China and the US: Differences in Hospital Admission Co-Variates and Outcomes." has been accepted by Vaccines.
  • 2021

  • Lei, Gao, Liu, Ren, Chen, Cao's paper entitled "Extracellular vesicles deposit PCNA to rejuvenate aged bone marrow–derived mesenchymal stem cells and slow age-related degeneration." has been accepted by Sci Transl Med.
  • Wu's paper entitled "Venetoclax Combined with Hypomethylating Agents for Treatment-Naïve B/Myeloid Mixed Phenotype Acute Leukemia." has been accepted by Case Reports in Hematology.
  • 2020

  • Lin, Miao, Hu, Zhang, Li's paper entitled "A 6-Membrane Protein Gene score for prognostic prediction of cytogenetically normal acute myeloid leukemia in multiple cohorts." has been accepted by J Cancer.
  • Li, Chen, Li, He, Yu's paper entitled "Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission." has been accepted by Leukemia.
  • He, Chen, Chen, Yuan, Fang's paper entitled "COVID-19 in persons with haematological cancers." has been accepted by Leukemia.
  • Li, Cao, Chen, Wu, Yu, Wang's paper entitled "Hematological features of persons with COVID-19." has been accepted by Leukemia.
  • Chen, Yu, He, Chen, Yuan, Dong's paper entitled "Risk factors for death in 1859 subjects with COVID-19." has been accepted by Leukemia.
  • 2019

  • Lin, Hu, Miao, Hu, Lei, Zhang's paper entitled "Identification of STAB1 in Multiple Datasets as a Prognostic Factor for Cytogenetically Normal AML: Mechanism and Drug Indications." has been accepted by Molecular Therapy - Nucleic Acids.
  • 2018

  • Liu, Wang, Jiang, Xie, Tang, Li's paper entitled "EVI1 expression predicts outcome in higher-risk myelodysplastic syndrome patients." has been accepted by Leukemia & Lymphoma.
  • Guo, Lin, Ren, Lei, Chen, Zhang's paper entitled "Enhanced Response of Acute Monocytic Leukemia Cells to Low-dose Cytarabine by 1,25-dihydroxyvitamin D3." has been accepted by CURR MED SCI.
  • 2017

  • Fu, Zhu, Wang, Zhang, Yuan, Chen's paper entitled "BCR-ABL1-positive microvesicles malignantly transform human bone marrow mesenchymal stem cells in vitro." has been accepted by Acta Pharmacol Sin.
  • Sun, Lu, Han, Qiu, Jin, Li's paper entitled "ANP32A dysregulation contributes to abnormal megakaryopoiesis in acute megakaryoblastic leukemia." has been accepted by Blood Cancer Journal.
  • Zhao, Kong, Liu, Yan, Gao, Guo's paper entitled "Tumor Cell-Derived Microvesicles Induced Not Epithelial-Mesenchymal Transition but Apoptosis in Human Proximal Tubular (HK-2) Cells: Implications for Renal Impairment in Multiple Myeloma." has been accepted by IJMS.
  • Wang, Li, Lu, Zhang, Hu, Li's paper entitled "The use of RGD-engineered exosomes for enhanced targeting ability and synergistic therapy toward angiogenesis." has been accepted by Nanoscale.